About
PTC Therapeutics is a global biopharmaceutical company that discovers, develops, and commercializes medicines for rare and serious diseases with high unmet medical needs, focusing on genetic disorders including Duchenne muscular dystrophy and phenylketonuria.
Explore PTC Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.